Tilman Brummer

7.8k total citations · 1 hit paper
98 papers, 4.3k citations indexed

About

Tilman Brummer is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Tilman Brummer has authored 98 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 30 papers in Oncology and 22 papers in Immunology. Recurrent topics in Tilman Brummer's work include Melanoma and MAPK Pathways (25 papers), Protein Tyrosine Phosphatases (14 papers) and Ubiquitin and proteasome pathways (13 papers). Tilman Brummer is often cited by papers focused on Melanoma and MAPK Pathways (25 papers), Protein Tyrosine Phosphatases (14 papers) and Ubiquitin and proteasome pathways (13 papers). Tilman Brummer collaborates with scholars based in Germany, Australia and United States. Tilman Brummer's co-authors include Roger J. Daly, Philippa M. O’Brien, Kate Patterson, Michael Reth, Robert Zeiser, Ricarda Herr, Shaima’a Hamarsheh, Olaf Groß, Michael Röring and Hassan Jumaa and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Tilman Brummer

93 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dual-specificity phosphatases: critical regulators with diverse cellular targets

2009 580 citations Kate Patterson, Tilman Brummer et al. Biochemical Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tilman Brummer Germany	35	2.9k	1.2k	897	547	468	98	4.3k
Masahiro Aoki Japan	31	3.6k 1.2×	1.3k 1.1×	752 0.8×	824 1.5×	377 0.8×	71	4.9k
Laura Soucek Spain	32	3.7k 1.3×	1.7k 1.5×	855 1.0×	858 1.6×	256 0.5×	54	5.0k
Sophie Tartare‐Deckert France	37	2.5k 0.9×	1.1k 0.9×	807 0.9×	636 1.2×	491 1.0×	63	4.0k
Chrysiis Michaloglou United Kingdom	8	3.3k 1.1×	1.4k 1.2×	1.1k 1.3×	810 1.5×	496 1.1×	12	5.5k
Norbert Schweifer Austria	28	2.8k 1.0×	1.1k 1.0×	428 0.5×	660 1.2×	303 0.6×	46	4.0k
Alexandre Arcaro Switzerland	31	2.6k 0.9×	659 0.6×	761 0.8×	351 0.6×	667 1.4×	51	3.9k
Michael Reedijk Canada	33	2.4k 0.8×	1.4k 1.2×	634 0.7×	731 1.3×	313 0.7×	50	3.7k
Ewa M. Michalak Australia	27	3.7k 1.3×	1.6k 1.4×	957 1.1×	640 1.2×	951 2.0×	37	5.2k
Ana C. Carrera Spain	42	3.3k 1.2×	1.1k 0.9×	1.6k 1.8×	509 0.9×	672 1.4×	96	5.4k
Manfred Jücker Germany	30	2.0k 0.7×	904 0.8×	518 0.6×	553 1.0×	199 0.4×	104	3.2k

Countries citing papers authored by Tilman Brummer

Since Specialization

Citations

This map shows the geographic impact of Tilman Brummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Brummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Brummer more than expected).

Fields of papers citing papers by Tilman Brummer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilman Brummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Brummer. The network helps show where Tilman Brummer may publish in the future.

Co-authorship network of co-authors of Tilman Brummer

This figure shows the co-authorship network connecting the top 25 collaborators of Tilman Brummer. A scholar is included among the top collaborators of Tilman Brummer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilman Brummer. Tilman Brummer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feuerstein, Reinhild, Lisa Marx, Ian J. Frew, et al.. (2026). Novel Syngeneic Cell Lines for Studying High-Risk BRAFV600E-Driven Colorectal Cancer In Vivo. Cancer Research Communications. 6(2). 320–339.

Schmidt, Carla, Luc Friboulet, Antoine Hollebecque, et al.. (2025). Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations. Nature Genetics. 58(1). 157–168.

Vogel, Arndt, Karthikeyan Murugesan, Júlia C.F. Quintanilha, et al.. (2024). Association of RNF43 Genetic Alterations With BRAF^V600E and MSI^high in Colorectal Cancer. JCO Precision Oncology. 8(8). e2300411–e2300411. 2 indexed citations

Haimovici, A, Melanie Boerries, Peter Bronsert, et al.. (2022). Spontaneous activity of the mitochondrial apoptosis pathway drives chromosomal defects, the appearance of micronuclei and cancer metastasis through the Caspase-Activated DNAse. Cell Death and Disease. 13(4). 315–315. 22 indexed citations

Oßwald, Lena, Shaima’a Hamarsheh, Franziska Maria Uhl, et al.. (2021). Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice. Molecular Cancer Research. 19(9). 1596–1608. 8 indexed citations

Reischmann, Nadine, et al.. (2020). BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation. Oncogene. 39(38). 6053–6070. 22 indexed citations

Mitschke, Julia, Manuel Schlimpert, Wilfried Reichardt, et al.. (2020). Cathepsin D deficiency in mammary epithelium transiently stalls breast cancer by interference with mTORC1 signaling. Nature Communications. 11(1). 5133–5133. 46 indexed citations

Hamarsheh, Shaima’a, Olaf Groß, Tilman Brummer, & Robert Zeiser. (2020). Immune modulatory effects of oncogenic KRAS in cancer. Nature Communications. 11(1). 5439–5439. 232 indexed citations

Köhler, M., Sebastian Halbach, Ulrike Burk, et al.. (2019). B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model. Oncogene. 38(8). 1324–1339. 11 indexed citations

10.

Diedrich, Britta, Kristoffer Rigbolt, Michael Röring, et al.. (2017). Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition. The EMBO Journal. 36(5). 646–663. 47 indexed citations

11.

Stickel, Natalie, Kathrin Hanke, Gabriele Prinz, et al.. (2017). MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation. Leukemia. 31(12). 2732–2741. 85 indexed citations

12.

Köhler, M. & Tilman Brummer. (2016). B-Raf activation loop phosphorylation revisited. Cell Cycle. 15(9). 1171–1173. 17 indexed citations

13.

Köhler, M., Michael Röring, Katharina Heilmann, et al.. (2015). Activation loop phosphorylation regulates B‐Raf in vivo and transformation by B‐Raf mutants. The EMBO Journal. 35(2). 143–161. 26 indexed citations

14.

Herr, Ricarda, M. Köhler, Hana Andrlová, et al.. (2014). B-Raf Inhibitors Induce Epithelial Differentiation in BRAF -Mutant Colorectal Cancer Cells. Cancer Research. 75(1). 216–229. 42 indexed citations

15.

Belenki, Dimitri, Konrad Aumann, Dietmar Pfeifer, et al.. (2014). Depletion of STAT5 blocks TEL–SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice. Blood Cancer Journal. 4(8). e240–e240. 12 indexed citations

16.

Erlmann, Patrik, et al.. (2012). The RhoGAP protein Deleted in Liver Cancer 3 (DLC3) is essential for adherens junctions integrity. Oncogenesis. 1(6). e13–e13. 33 indexed citations

17.

Halbach, Sebastian, Konrad Aumann, Sven Schwemmers, et al.. (2012). Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia. 27(1). 118–129. 42 indexed citations

18.

Patterson, Kate, Tilman Brummer, Philippa M. O’Brien, & Roger J. Daly. (2009). Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochemical Journal. 418(3). 475–489. 580 indexed citations breakdown →

19.

Brummer, Tilman, Mark Larance, Paul Timpson, et al.. (2009). The docking protein and proto-oncogene product Gab2 is regulated via a novel negative feedback mechanism mediated by 14-3-3 binding. Cell Communication and Signaling. 7(S1). 4 indexed citations

20.

Brummer, Tilman, Mark Larance, Maria Teresa Herrera Abreu, et al.. (2008). Phosphorylation‐dependent binding of 14‐3‐3 terminates signalling by the Gab2 docking protein. The EMBO Journal. 27(17). 2305–2316. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact